MICHAEL S PERRY
CIK 1250379 · Chief Executive Officer · last filed 2025-12-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.87M
Companies
6
Total Filings
52
Lifetime Open-Market Net
-$11.94M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARWR | Director | 123,059 | $74.52 | $9.17M | -$8.32M | 24 | 2025-12-18 |
| RCEL | Chief Executive Officer | 406,525 | $3.91 | $1.59M | -$3.81M | 9 | 2022-11-22 |
| ARMP | Director | — | $7.58 | — | $0 | 1 | 2019-05-24 |
| Armata Pharmaceuticals, Inc. (APHB) Delisted | Director | 411,335 | — | — | $200.0K | 3 | 2018-03-26 |
| PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | President & CMO | 81,860 | — | — | -$16.9K | 7 | 2011-04-14 |
| TGEN | Director | 20,000 | $5.73 | $114.6K | $0 | 3 | 2009-06-02 |
Recent Filings · Page 3 of 6
52 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-09-11 | ARWR | Sell (S) | −185,000 | -$5.44M | EDGAR |
| 2019-05-24 | ARMP | Grant (A) | — | $0 | EDGAR |
| 2019-01-03 | ARWR | Grant (A) | +36,000 | $0 | EDGAR |
| 2018-03-26 | Armata Pharmaceuticals, Inc. (APHB) Delisted | Buy (P) | +292,592 | $200.0K | EDGAR |
| 2018-01-03 | ARWR | Grant (A) | +30,000 | $0 | EDGAR |
| 2017-09-12 | Armata Pharmaceuticals, Inc. (APHB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-04 | ARWR | Grant (A) | +80,000 | $0 | EDGAR |
| 2016-01-04 | ARWR | Grant (A) | +30,000 | $0 | EDGAR |
| 2015-09-23 | Armata Pharmaceuticals, Inc. (APHB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-06 | ARWR | Grant (A) | +30,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.